Overview

• Materials solutions innovator's Q4 sales rose 2%, beating analyst expectations

• Adjusted EPS for Q4 grew 14% yr/yr, driven by organic sales growth

• 2026 adjusted EPS forecasted to grow 4% to 12%

Outlook

• Avient expects 2026 adjusted EPS between $2.93 and $3.17, up 4% to 12%

• Company projects Q1 2026 adjusted EPS at $0.81, 7% growth over prior year

• Avient anticipates free cash flow exceeding $200 mln in 2026

Result Drivers

• SPECIALTY ENGINEERED MATERIALS - Organic sales growth in this segment drove Q4 adjusted EPS growth, per CEO Dr. Ashish Khandpur

• PRODUCTIVITY INITIATIVES - Company-wide productivity measures contributed to adjusted EPS growth and margin expansion, per CEO Dr. Ashish Khandpur

• FOREIGN EXCHANGE IMPACT - Favorable foreign exchange contributed 3% to Q4 sales growth

Key Details

Analyst Coverage

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"

• The average consensus recommendation for the specialty chemicals peer group is "buy"

• Wall Street's median 12-month price target for Avient Corp is $42.00, about 2.8% above its February 11 closing price of $40.87

• The stock recently traded at 13 times the next 12-month earnings vs. a P/E of 11 three months ago

Press Release: ID:nPn8TzYVLa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)